ProShares Ultra Nasdaq Biotechnology (BIB)

Assets	$77.46M
Expense Ratio	0.95%
PE Ratio	n/a
Shares Out	930,000
Dividend (ttm)	$0.49
Dividend Yield	0.58%
Ex-Dividend Date	Mar 25, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	5,041
Open	82.95
Previous Close	83.19
Day's Range	82.85 - 85.10
52-Week Low	39.56
52-Week High	90.91
Beta	1.25
Holdings	263
Inception Date	Apr 8, 2010

About BIB

Fund Home Page

The ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. BIB was launched on Apr 8, 2010 and is issued by ProShares.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NASDAQ
• Ticker Symbol: BIB
• ETF Provider: ProShares
• Index Tracked: NASDAQ / Biotechnology

Top 10 Holdings

152.36% of assets

Name	Symbol	Weight
NASDAQ BIO INDEX SWAP BNP PARIBAS	n/a	37.71%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	n/a	27.57%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	n/a	26.40%
NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL	n/a	20.65%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	n/a	17.22%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	n/a	4.95%
Gilead Sciences, Inc.	GILD	4.79%
Vertex Pharmaceuticals Incorporated	VRTX	4.68%
Amgen Inc.	AMGN	4.54%
Regeneron Pharmaceuticals, Inc.	REGN	3.85%

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 25, 2026	$0.00714	Mar 31, 2026
Dec 24, 2025	$0.13464	Dec 31, 2025
Sep 24, 2025	$0.18054	Sep 30, 2025
Jun 25, 2025	$0.17058	Jul 1, 2025
Mar 26, 2025	$0.13094	Apr 1, 2025
Dec 23, 2024	$0.39644	Dec 31, 2024

Performance

BIB had a total return of 116.56% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.61%.